Biblio

Export 1208 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is R  [Clear All Filters]
Journal Article
K. J. Edmunds, Driscoll, I., Hagen, E. W., Barnet, J. H., Ravelo, L. A., Plante, D. T., Gaitán, J. M., Lose, S. R., Motovylyak, A., Bendlin, B. B., Okonkwo, O. C., and Peppard, P. E., “Cardiorespiratory Fitness Attenuates the Deleterious Effects of Sleep Apnea on Cerebral Structure and Perfusion in the Wisconsin Sleep Cohort Study.”, J Alzheimers Dis, vol. 95, no. 2, pp. 427-435, 2023.
E. Rotondo, Galimberti, D., Mercurio, M., Giardinieri, G., Forti, S., Vimercati, R., Borracci, V., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Nobili, A., Scarpini, E., and Arighi, A., “Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1045-1052, 2022.
G. Ransmayr, Hermann, P., Sallinger, K., Benke, T., Seiler, S., Dal-Bianco, P., Marksteiner, J., Defrancesco, M., Sanin, G., Struhal, W., Guger, M., Vosko, M., Hagenauer, K., Lehner, R., Futschik, A., and Schmidt, R., “Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.”, J Alzheimers Dis, vol. 63, no. 1, pp. 103-114, 2018.
D. Renard, Tatu, L., Collombier, L., Wacongne, A., Ayrignac, X., Charif, M., Boukriche, Y., Chiper, L., Fourcade, G., Azakri, S., Gaillard, N., Mercier, E., Lehmann, S., and Thouvenot, E., “Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1113-1121, 2018.
S. L. Gardener, Sohrabi, H. R., Shen, K. - K., Rainey-Smith, S. R., Weinborn, M., Bates, K. A., Shah, T., Foster, J. K., Lenzo, N., Salvado, O., Laske, C., Laws, S. M., Taddei, K., Verdile, G., and Martins, R. N., “Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 52, no. 2, pp. 661-72, 2016.
J. Krzysztof Blusztajn, Aytan, N., Rajendiran, T., Mellott, T. J., Soni, T., Burant, C. F., Serrano, G. E., Beach, T. G., Lin, H., and Stein, T. D., “Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1623-1634, 2023.
L. Beishon, Haunton, V. J., Panerai, R. B., and Robinson, T. G., “Cerebral Hemodynamics in Mild Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 59, no. 1, pp. 369-385, 2017.
F. Rokad, Moseley, R., Hardy, R. S., Chukkapalli, S., Crean, S. J., Kesavalu, L., and Singhrao, S. K., “Cerebral Oxidative Stress and Microvasculature Defects in TNF-α Expressing Transgenic and Porphyromonas gingivalis-Infected ApoE-/- Mice.”, J Alzheimers Dis, vol. 60, no. 2, pp. 359-369, 2017.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., “Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
D. Renard, Gabelle, A., Hirtz, C., Demattei, C., Thouvenot, E., and Lehmann, S., “Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Isolated Supratentorial Cortical Superficial Siderosis.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1291-1295, 2016.
S. Wolfsgruber, Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., Kornhuber, J., Lewczuk, P., Jessen, F., and Wagner, M., “Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 3, pp. 939-950, 2017.
A. P. Ingber, Hassenstab, J., Fagan, A. M., Benzinger, T. L. S., Grant, E. A., Holtzman, D. M., Morris, J. C., and Roe, C. M., “Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1055-64, 2016.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
S. P. Arnerić, Batrla-Utermann, R., Beckett, L., Bittner, T., Blennow, K., Carter, L., Dean, R., Engelborghs, S., Genius, J., Gordon, M. Forrest, Hitchcock, J., Kaplow, J., Luthman, J., Meibach, R., Raunig, D., Romero, K., Samtani, M. N., Savage, M., Shaw, L., Stephenson, D., Umek, R. M., Vanderstichele, H., Willis, B., and Yule, S., “Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.”, J Alzheimers Dis, vol. 55, no. 1, pp. 19-35, 2017.
A. Rivero-Santana, Ferreira, D., Perestelo-Pérez, L., Westman, E., Wahlund, L. - O., Sarría, A., and Serrano-Aguilar, P., “Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.”, J Alzheimers Dis, vol. 55, no. 2, pp. 625-644, 2017.
L. Calderón-Garcidueñas, Avila-Ramírez, J., Calderón-Garcidueñas, A., González-Heredia, T., Acuña-Ayala, H., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Cortés-González, V., Martínez-Martínez, L., García-Pérez, M. Alberto, Reis, J., Mukherjee, P. S., Torres-Jardón, R., and Lachmann, I., “Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.”, J Alzheimers Dis, vol. 54, no. 2, pp. 597-613, 2016.
L. Calderón-Garcidueñas, Avila-Ramírez, J., Calderón-Garcidueñas, A., González-Heredia, T., Acuña-Ayala, H., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Cortés-González, V., Martínez-Martínez, L., García-Pérez, M. Alberto, Reis, J., Mukherjee, P. S., Torres-Jardón, R., and Lachmann, I., “Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.”, J Alzheimers Dis, vol. 54, no. 2, pp. 597-613, 2016.
A. Arighi, Di Cristofori, A., Fenoglio, C., Borsa, S., D'Anca, M., Fumagalli, G. Giulio, Locatelli, M., Carrabba, G., Pietroboni, A. Margherita, Ghezzi, L., Carandini, T., Colombi, A., Scarioni, M., De Riz, M. Alessandra, Serpente, M., Rampini, P. Maria, Scarpini, E., and Galimberti, D., “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
N. P. Rocha, Toledo, A., Corgosinho, L. T. S., de Souza, L. C., Guimarães, H. C., Resende, E. P. F., Braz, N. F. T., Gomes, K. B., Silva, A. C. Simoes E., Caramelli, P., and Teixeira, A. L., “Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
N. P. Rocha, Toledo, A., Corgosinho, L. T. S., de Souza, L. C., Guimarães, H. C., Resende, E. P. F., Braz, N. F. T., Gomes, K. B., Silva, A. C. Simoes E., Caramelli, P., and Teixeira, A. L., “Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1085-1090, 2018.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., “Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., “Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
A. De Vos, Struyfs, H., Jacobs, D., Fransen, E., Klewansky, T., De Roeck, E., Robberecht, C., Van Broeckhoven, C., Duyckaerts, C., Engelborghs, S., and Vanmechelen, E., “The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1523-38, 2016.
A. Piriz, Reyes, D., Narkhede, A., Guzman, V. A., Viqar, F., Meier, I. B., Budge, M., Mena, P., Dashnaw, S., Lee, J., Reitz, C., Gutierrez, J., Campos, L., Medrano, M., Lantigua, R., Mayeux, R., and Brickman, A. M., “Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1519-1528, 2018.
A. Piriz, Reyes, D., Narkhede, A., Guzman, V. A., Viqar, F., Meier, I. B., Budge, M., Mena, P., Dashnaw, S., Lee, J., Reitz, C., Gutierrez, J., Campos, L., Medrano, M., Lantigua, R., Mayeux, R., and Brickman, A. M., “Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1519-1528, 2018.

Pages